Dr Janin Chandra
Senior Scientist, Admedus Immunotherapies
Adjunct Research Fellow, University of Queensland Diamantina Institute
Janin Chandra studied Biology at the University of Frankfurt in her home country Germany. She conducted her master thesis at the Federal Institute for Sera and Vaccines in the Department of Immunology in Langen, Germany, where she investigated the impact of vaccinia virus‐induced type I interferons on specific T cell expansion. Janin was accepted at the Life Science Zurich Graduate School in Switzerland. In the Department of Experimental Immunology of the University of Zurich and together with Prof. Burkhard Becher she studied the role of non-canonical NFkB‐signaling in cell‐mediated immunity and autoimmunity. It was then that Janin specialized in antigen-presenting cells and their properties in health and disease. In 2012, Janin received a UQ 3-year post-doctoral research fellowship to join Prof. Ian Frazer’s research team at UQDI. Her studies focused on human papillomavirus (HPV) induced malignancies and the role of different types of dendritic cells in HPV-induced hyperplasia of the skin. In 2015, Janin joined the team of Admedus Vaccines Pty Ltd as Senior Scientist, a UQ spin off company located at the Translational Research Institute, which aims to develop immunotherapeutic vaccine strategies to combat chronic herpes-simplex 2 infections and HPV-induced malignancies. Janin will return to UQ as research fellow early 2019 to continue her research in dendritic cell biology and HPV-targeted immunotherapy.
Sign up for Email updates
Receive information including deadline reminders, speaker profiles, program changes and much more...